Running a NVCT wheel strategy lets you generate consistent premium income on Nuvectis Pharma Inc while setting your own entry and exit prices on the underlying. Nuvectis Pharma Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own NVCT, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best NVCT wheel strategy setups in real time.
The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on NVCT, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable NVCT wheel from a losing one.
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the NVCT wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your NVCT wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.
